#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>Positive: Presence of C. trachomatis by nucleic acid probe. Negative: Absence of C. trachomatis by nucleic acid probe.
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Nucleic-acid amplification tests (NAAT) are superior to direct DNA probe testing for detection of Chlamydia trachomatis. For NAAT, refer to Chlamydia trachomatis & Neisseria gonorrhoeae by Amplified Detection (APTIMA®) (0060241) or Chlamydia trachomatis by Amplified Detection (APTIMA®) (0060243). Closely observe instructions for specimen collection and transport using test-specific kits provided by the manufacturer for each specimen type. Culture is recommended for Chlamydia trachomatis detection in cases of suspected sexual abuse or suspected failure of therapy.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
Amplification tests are recommended for detection of Chlamydia trachomatis from genitourinary sources. Refer to Chlamydia trachomatis by Amplified DNA Detection (APTIMA®) (0060243). Direct DNA probe testing is appropriate only for endocervical, urethral, and conjunctival specimens. Specimens must be collected and transported in test-specific kits provided by the manufacturer. Culture is recommended for Chlamydia trachomatis detection in cases of suspected sexual abuse or suspected failure of therapy.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
87490
|
*ExistCPT>